CORONAVIRUS/Taiwan COVID vaccine maker to apply for EUA after promising Phase II trial results
06/10/2021 05:39 PM
Taipei, June 10 (CNA) Medigen Vaccine Biologics Corp., a Taiwan-based biopharmaceutical company, said Thursday that it would seek an Emergency Use Authorization (EUA) for its COVID-19 vaccine candidate after unblinding the results of its Phase II clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Taiwan COVID-19 News Briefs: May 27]()
Taiwan COVID-19 News Briefs: May 27Taiwan on Friday reported 94,855 new COVID-19 cases -- 94,808 domestic infections and 47 imported -- and a single-day high of 126 deaths from the disease, according to the ...05/27/2022 11:26 PM![COVID to remain at 'high but stable plateau' for 2 weeks: health minister]()
COVID to remain at 'high but stable plateau' for 2 weeks: health ministerHealth Minister Chen Shih-chung (陳時中) said Friday that the COVID-19 pandemic in Taiwan has started to plateau at a high but stable level that will last a minimum of two weeks.05/27/2022 09:27 PM![Taiwan to offer free rapid COVID tests to children aged 6 or younger]()
Taiwan to offer free rapid COVID tests to children aged 6 or youngerFree COVID-19 rapid antigen tests will be provided to families with children aged six or younger, starting in June, according to the Central Epidemic Command Center (CECC) on ...05/27/2022 07:04 PM
Latest
- Politics
Taiwan signs LOI with financing bank to help Belizean economy
05/27/2022 11:32 PM - Society
Taiwan COVID-19 News Briefs: May 27
05/27/2022 11:26 PM - Society
Taiwan court says ruling on custody case over daughter unconstitutional
05/27/2022 11:14 PM - Business
Taipei introduces NT$2.85 billion COVID-19 bailout package
05/27/2022 10:41 PM - Business
New electricity rates for electric car owners to take effect May 30
05/27/2022 09:55 PM